AlphaMadera's AlphaVal page classifies Community Healthcare Trust Incorporated as a Real Estate Investment Trust business and values it using P/FFO × Healthcare REIT Multiple, then compares the result to the current market price to flag CHCT as undervalued, fairly valued, or overvalued.

What is Community Healthcare Trust Incorporated's fair value?

Fair value for CHCT comes from a P/FFO × Healthcare REIT Multiple model -- the approach AlphaVal selected for this company's Real Estate Investment Trust classification. The live AlphaVal page shows bear, base, and bull scenarios alongside the key assumption behind each.

How does AlphaMadera value CHCT?

AlphaVal routes each company to one of ten valuation archetypes based on its business model. CHCT was classified as Real Estate Investment Trust and is valued using P/FFO × Healthcare REIT Multiple, built from CHCT's most recent reported fundamentals.

CHCT - Community Healthcare Trust Incorporated

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $17.00 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Real Estate Investment Trust 85% confidence

Primary model: P/FFO × Healthcare REIT Multiple

Valuation Signal Undervalued Strong

Trading 51.9% below fair value

Current Price $14.95

Bear Case $24.73 65.4% upside ($24.73 - $14.95) / $14.95 = 65.4% $1.70 FFO × 15x

Fair Value $31.09 108.0% upside ($31.09 - $14.95) / $14.95 = 108.0% $1.70 FFO × 20x

Bull Case $37.45 150.5% upside ($37.45 - $14.95) / $14.95 = 150.5% $1.70 FFO × 24x

Adjust Assumptions

P/FFO Multiple

19.7x

FFO per Share

1.7$

Key Value Driver

FFO/share ($1.70) × healthcare P/FFO multiple

Terminal Value % of EV

Implied Market Multiple 8.8x

Market is pricing in (growth)

Plain-Language Summary

At $1.70 FFO/share with a 20x healthcare REIT multiple, the base-case value is $31.09 per share. Dividend yield: 11.8%. DDM cross-check: $25.43.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (16 analysts) $17.00

Analyst Range $17.00 – $17.00

Divergence from AlphaVal 83%

Warnings

⚠ Standard profit figures are misleading for real estate companies — large non-cash accounting charges make profits look artificially low. Dividend yield and funds from operations are better measures.

⚠ Dividend yield of 11.8% is unusually high — make sure the company generates enough cash to keep paying it.

ℹ Wall Street's average price target is $17.00 (from 16 analysts). Our estimate is 83% above the consensus -- consider that gap carefully.

Key Risks

P/E and EV/EBITDA are structurally wrong for REITs — use P/FFO and NAV
Interest rate sensitivity: REIT multiples compress when rates rise
FFO approximation (NI + D&A) may include gains on property sales — verify